AIMMUNE THERAPEUTICS INC. - Daily - Technical analysis published on 08/14/2019 (GMT)
- Who voted?
- 202
- 0
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
AIMMUNE THERAPEUTICS INC. Chart
Summary of the analysis
Trends
Court terme:
Strongly bullish
De fond:
Slightly bullish
Technical indicators
83%
6%
11%
My opinion
Bullish above 21.52 USD
My targets
26.61 USD (+23.42%)
29.62 USD (+37.38%)
My analysis
The short-term increase currently reinforces the basic trend, which is only slightly bullish. It would be possible for traders to only trade long positions (at the time of purchase) on AIMMUNE THERAPEUTICS INC. as long as the price remains well above 21.52 USD. The buyers” bullish objective is set at 26.61 USD. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 29.62 USD. If there is any crossing, the next objective would be the resistance located at 32.18 USD.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay.
Additional analysis
Quotes
The AIMMUNE THERAPEUTICS INC. price is 21.56 USD. The price registered an increase of +7.10% on the session with the lowest point at 20.12 USD and the highest point at 21.67 USD. The deviation from the price is +7.16% for the low point and -0.51% for the high point.20.12
21.67
21.56
The Central Gaps scanner detects a bullish opening marking the presence of sellers ahead of buyers at the opening but not sufficiently marked to allow the price to register a quotation gap.
Bearish opening
Type : Bearish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by AIMMUNE THERAPEUTICS INC.:
Technical
Technical analysis of AIMMUNE THERAPEUTICS INC. in Daily shows an overall slightly bullish trend. 60.71% of the signals given by moving averages are bullish. This slightly bullish trend could be reinforced by the strong bullish signals given by short-term moving averages. The Central Indicators market scanner is currently detecting several bullish signals that could impact this trend:
Bullish trend reversal : Moving Average 50
Type : Bullish
Timeframe : Daily
Bullish trend reversal : adaptative moving average 50
Type : Bullish
Timeframe : Daily
Bullish price crossover with Moving Average 50
Type : Bullish
Timeframe : Daily
Bullish price crossover with adaptative moving average 20
Type : Bullish
Timeframe : Daily
In fact, 15 technical indicators on 18 studied are currently positioned bullish. Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Weekly
RSI indicator is back over 50
Type : Bullish
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found these results:
Horizontal resistance is broken
Type : Bullish
Timeframe : Daily
Resistance of channel is broken
Type : Bullish
Timeframe : Daily
Resistance of triangle is broken
Type : Bullish
Timeframe : Daily
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 16.43 | 19.01 | 21.52 | 21.56 | 26.61 | 29.62 | 32.18 |
| Change (%) | -23.79% | -11.83% | -0.19% | - | +23.42% | +37.38% | +49.26% |
| Change | -5.13 | -2.55 | -0.04 | - | +5.05 | +8.06 | +10.62 |
| Level | Major | Major | Intermediate | - | Major | Minor | Intermediate |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 17.95 | 18.48 | 19.30 | 19.83 | 20.65 | 21.18 | 22.00 |
| Camarilla | 19.76 | 19.88 | 20.01 | 20.13 | 20.25 | 20.38 | 20.50 |
| Woodie | 18.11 | 18.55 | 19.46 | 19.90 | 20.81 | 21.25 | 22.16 |
| Fibonacci | 18.48 | 18.99 | 19.31 | 19.83 | 20.34 | 20.66 | 21.18 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 17.36 | 17.87 | 18.57 | 19.08 | 19.78 | 20.29 | 20.99 |
| Camarilla | 18.93 | 19.04 | 19.15 | 19.26 | 19.37 | 19.48 | 19.59 |
| Woodie | 17.45 | 17.92 | 18.66 | 19.13 | 19.87 | 20.34 | 21.08 |
| Fibonacci | 17.87 | 18.34 | 18.62 | 19.08 | 19.55 | 19.83 | 20.29 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 12.40 | 14.68 | 16.96 | 19.24 | 21.52 | 23.80 | 26.08 |
| Camarilla | 18.00 | 18.41 | 18.83 | 19.25 | 19.67 | 20.09 | 20.50 |
| Woodie | 12.41 | 14.68 | 16.97 | 19.24 | 21.53 | 23.80 | 26.09 |
| Fibonacci | 14.68 | 16.42 | 17.50 | 19.24 | 20.98 | 22.06 | 23.80 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 66.47 | |
| MACD (12,26,9): | 0.1500 | |
| Directional Movement: | 17.92 | |
| AROON (14): | 42.86 | |
| DEMA (21): | 19.59 | |
| Parabolic SAR (0,02-0,02-0,2): | 18.02 | |
| Elder Ray (13): | 1.27 | |
| Super Trend (3,10): | 18.29 | |
| Zig ZAG (10): | 21.56 | |
| VORTEX (21): | 1.0600 | |
| Stochastique (14,3,5): | 78.76 | |
| TEMA (21): | 19.93 | |
| Williams %R (14): | -3.35 | |
| Chande Momentum Oscillator (20): | 2.77 | |
| Repulse (5,40,3): | 14.8100 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | -0.1000 | |
| Courbe Coppock: | 11.81 |
| MA7: | 19.66 | |
| MA20: | 19.15 | |
| MA50: | 19.70 | |
| MA100: | 20.34 | |
| MAexp7: | 19.97 | |
| MAexp20: | 19.52 | |
| MAexp50: | 19.73 | |
| MAexp100: | 20.53 | |
| Price / MA7: | +9.66% | |
| Price / MA20: | +12.58% | |
| Price / MA50: | +9.44% | |
| Price / MA100: | +6.00% | |
| Price / MAexp7: | +7.96% | |
| Price / MAexp20: | +10.45% | |
| Price / MAexp50: | +9.28% | |
| Price / MAexp100: | +5.02% |
News
The latest news and videos published on AIMMUNE THERAPEUTICS INC. at the time of the analysis were as follows:
- Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results and Recent Operational Highlights
- Aimmune to Present at the JMP Securities Life Sciences Conference
- U.S. FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut Allergy
- Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights
- Investor Expectations to Drive Momentum within L3 Technologies, The Goldman Sachs Group, Genuine Parts, Bruker, Omeros, and Aimmune Therapeutics — Discovering Underlying Factors of Influence
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis AIMMUNE THERAPEUTICS INC. - Daily